No abstract available
Keywords:
interaction; novel oral anticoagulants; pulmonary embolism.
MeSH terms
-
Aged
-
Antibiotics, Antitubercular* / administration & dosage
-
Antibiotics, Antitubercular* / adverse effects
-
Antibiotics, Antitubercular* / pharmacokinetics
-
Anticoagulants* / administration & dosage
-
Anticoagulants* / adverse effects
-
Anticoagulants* / pharmacokinetics
-
Atrial Fibrillation / therapy*
-
Ciprofloxacin* / administration & dosage
-
Ciprofloxacin* / adverse effects
-
Ciprofloxacin* / pharmacokinetics
-
Coronary Artery Bypass*
-
Drug Incompatibility
-
Female
-
Humans
-
Morpholines / administration & dosage
-
Morpholines / adverse effects
-
Morpholines / pharmacokinetics
-
Rifampin* / administration & dosage
-
Rifampin* / adverse effects
-
Rifampin* / pharmacokinetics
-
Rivaroxaban
-
Thiophenes / administration & dosage
-
Thiophenes / adverse effects
-
Thiophenes / pharmacokinetics
Substances
-
Antibiotics, Antitubercular
-
Anticoagulants
-
Morpholines
-
Thiophenes
-
Ciprofloxacin
-
Rivaroxaban
-
Rifampin